Abstract

Carotid artery stenting (CAS) is an established treatment for patients at high-risk for endarterectomy. Patients who undergo CAS have been shown to have periprocedural microembolic events on transcranial Doppler ultrasonography. Flow reversal is often applied in these situations to prevent distal emboli and concurrently allow blood to flush into the common carotid artery. Patients who demonstrate soft plaque morphology that may embolize distally during CAS benefit from flow reversal. Even so, the all-stroke risk in these patients is nearly 1.4%. High-risk patients typically have more difficult plaque morphology; flow reversal decreases the rate of distal emboli but does not offer the intraprocedural visualization seen with intravascular ultrasound (IVUS). In this paper, we illustrate potential periprocedural outcomes associated with stenting of the stenotic carotid bifurcation under flow reversal and how IVUS influenced endovascular management. Three high-risk patients who underwent CAS with direct common carotid artery cutdown approaches due to common carotid ostia disease with flow-reversal proximal embolic protection also had intraprocedural IVUS performed to evaluate plaque morphology and stability before the protection system was removed. Case 1 illustrates no intraluminal thrombus on IVUS, requiring no further intervention after stent placement. Case 2 demonstrates intraluminal thrombus on IVUS requiring a second stent to stabilize plaque. Case 3 shows the inadequate resolution of thrombus after a second stent, which was addressed with balloon angioplasty. In our experience, using IVUS as an adjunct to CAS under proximal embolic protection helped demonstrate plaque morphology and plaque fragmentation after stent placement. These cases illustrate the potential benefit of allowing stabilization of the plaque before flow reversal is stopped.

Highlights

  • Carotid artery stenting (CAS) was initially introduced as a treatment alternative for patients deemed high risk for carotid endarterectomy

  • High-risk patients typically have more difficult plaque morphology; flow reversal decreases the rate of distal emboli but does not offer the intraprocedural visualization seen with intravascular ultrasound (IVUS)

  • Due to vessel tortuosity in the setting of free thrombus proximal to the lesion as well as high bifurcation (Figure 1A-1C), the patient was taken to the angiography suite for carotid stent placement with angioplasty using a direct carotid cut-down approach given his proximal common carotid artery stenosis with proximal flow reversal embolic protection

Read more

Summary

Introduction

Carotid artery stenting (CAS) was initially introduced as a treatment alternative for patients deemed high risk for carotid endarterectomy. High-risk factors included medical comorbidities, poor surgical anatomy (such as a high carotid bifurcation, previous neck surgery, spinal immobility, recurrent stenosis), and advanced age [1,2,3]. Several trials have compared stenting to endarterectomy. The Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) was the largest randomized controlled trial and demonstrated no significant difference in the composite outcome of stroke, myocardial infarction, and death within 30 days [1,4]. The incidence of periprocedural stroke was greater in the stenting group, whereas the incidence of myocardial infarction was greater in the carotid endarterectomy group. Technological advancements in embolization prevention during CAS are aimed at diminishing adverse periprocedural neurological complications

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call